Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL875150

O=S(=O)([O-])C(F)(F)F.O=S(=O)([O-])C(F)(F)F.O=S(=O)([O-])C(F)(F)F.[Fe+3]

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA7 P43166 1/20 0.44
CA13 Q8N1Q1 1/20 0.44
GPR3 P46089 2/20 0.42
ACHE P22303 2/20 0.33
KCNH2 Q12809 6/20 0.31
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
TSHR P16473 1/20 0.31
KMT2A Q03164 1/20 0.31
F2 P00734 1/20 0.30
PRSS1 P07477 1/20 0.30
PRSS2 P07478 1/20 0.30
PRSS3 P35030 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL117665 0.92 CA1 (0.44) CA1CA2CA7CA13GPR3
Trifluoromethanesulfonic Acid SCHEMBL25292878 0.92 CA1 (0.44) CA1CA2CA7CA13GPR3
Trifluoromethanesulfonic Acid SCHEMBL20570425 0.92
Trifluoromethanesulfonic Acid SCHEMBL25292546 0.92 GPR3 (0.48) CA1CA2CA7CA13GPR3
Trifluoromethanesulfonic Acid SCHEMBL25287606 0.92 CA1 (0.44) CA1CA2CA7CA13GPR3
Trifluoromethanesulfonic Acid SCHEMBL25301943 0.92 CA1 (0.44) CA1CA2CA7CA13GPR3
Trifluoromethanesulfonic Acid SCHEMBL23430060 0.92 CA1 (0.44) CA1CA2CA7CA13GPR3
Trifluoromethanesulfonic Acid SCHEMBL25285896 0.92 CA1 (0.44) CA1CA2CA7CA13GPR3
Trifluoromethanesulfonic Acid SCHEMBL25255863 0.92 CA1 (0.44) CA1CA2CA7CA13GPR3
Trifluoromethanesulfonic Acid SCHEMBL18788979 0.92 CA1 (0.44) CA1CA2CA7CA13GPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1199 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117440957-B Process for the production of biotin intermediates DSM IP ASSETS B.V. (NL) 2026-05-26 CN claimed
CN-122079788-A Green synthesis method of methane-methylamine hydrochloride based on continuous flow technology 2026-05-26 CN claimed
CN-122079748-A Guaazulene triarylmethane, synthesis method and application thereof in preparation of antibacterial products 2026-05-26 CN claimed
CN-122079789-A Green synthesis method of deuterated methylamine hydrochloride based on continuous flow technology 2026-05-26 CN claimed
CN-122059808-A Method for selectively synthesizing isopentenyl phenol compounds 兰州石化职业技术大学 2026-05-19 CN claimed
CN-122036489-A Photocatalysis method for degrading polystyrene into benzoic acid 国科大杭州高等研究院 2026-05-15 CN claimed
CN-122010701-A Carbonyl compound and preparation method thereof 南京工业大学 2026-05-12 CN claimed
EP-4724512-A1 METHOD FOR SYNTHESISING A GLYCEROL POLYESTER AND GLYCEROL POLYESTER OBTAINED THEREBY COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) 2026-04-15 EP claimed
US-20260071340-A1 CATALYST FOR WATER ELECTROLYSIS ELECTRODE, METHOD FOR PREPARING THE CATALYST, AND WATER ELECTROLYSIS ELECTRODE SK INNOVATION CO LTD (KR) 2026-03-12 US claimed
EP-4707430-A2 CATALYST FOR WATER ELECTROLYSIS ELECTRODE, PREPARING METHOD OF CATALYST FOR WATER ELECTROLYSIS ELECTRODE, WATER ELECTROLYSIS ELECTRODE, AND WATER ELECTROLYSIS SYSTEM SK Innovation Co., Ltd. (KR) 2026-03-11 EP claimed
US-20140272570-A1 High Energy Cathode Material WILDCAT DISCOVERY TECHNOLOGIES, INC. (US) 2014-09-18 US claimed
WO-2014062438-A2 SOLUTION-BASED MERCURY CAPTURE NOVINDA CORPORATION (US) 2014-04-24 WO claimed
WO-2014043468-A1 METHODS OF PRODUCING PARA-XYLENE AND TEREPHTHALIC ACID MICROMIDAS INC. (US) 2014-03-20 WO claimed
WO-2014011199-A1 CONVERSION OF OLIGOMERIC STARCH, CELLULOSE, OR SUGARS TO HYDROCARBONS LOS ALAMOS NATIONAL SECURITY, LLC (US) 2014-01-16 WO claimed
US-20130245316-A1 METHODS OF PRODUCING PARA-XYLENE AND TEREPHTHALIC ACID MICROMIDAS, INC. (US) 2013-09-19 US claimed
US-20110306782-A1 New Catalytic System for Cross-Coupling Reactions CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S) (FR) 2011-12-15 US claimed
US-20090326240-A1 Iron-Copper Co-Catalyzed Process for Carbon-Carbon or Carbon-Heteroatom Bonding CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) 2009-12-31 US claimed
US-6951934-B2 Method for preparing functionalized β-(1,3)-glucan derivatives LABORATORIES GOEMAR (FR) 2005-10-04 US claimed
US-6156235-A Conductive elastomeric foams by in-situ vapor phase polymerization of pyrroles WORLD PROPERTIES, INC. (US) 2000-12-05 US claimed
US-4088823-A CARBOXYLIC ACID, COPPER, COBALT OR IRON COMPOUND, INORGANIC BROMINE COMPOUND PHILLIPS PETROLEUM COMPANY (US) 1978-05-09 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260071340-A1 CATALYST FOR WATER ELECTROLYSIS ELECTRODE, METHOD FOR PREPARING THE CATALYST, AND WATER ELECTROLYSIS ELECTRODE SLC9A2, FECH, SLC9A1 CA1 81/4885CA2 145/4885CA7 540/4885
US-20110306782-A1 New Catalytic System for Cross-Coupling Reactions FECH, HCCS, CTRC CA1 91/4885CA2 87/4885CA7 130/4885
US-20130245316-A1 METHODS OF PRODUCING PARA-XYLENE AND TEREPHTHALIC ACID DCXR, DDT, HPD CA1 1384/4885CA2 3521/4885CA7 1816/4885
US-20090326240-A1 Iron-Copper Co-Catalyzed Process for Carbon-Carbon or Carbon-Heteroatom Bonding FECH, HCCS, SOD1 CA1 276/4885CA2 157/4885CA7 155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.